298 related articles for article (PubMed ID: 11316064)
1. Analysis of the CD40/CD40L role in the sustenance of alloreactive antibody production.
Shoker AS; Lun ZR; Choudry R; Saxena A
Transpl Immunol; 2001 Feb; 8(4):219-28. PubMed ID: 11316064
[TBL] [Abstract][Full Text] [Related]
2. Production of human alloreactive antibodies by uremic sensitized lymphocytes engrafted in severe combined immunodeficient mice.
Shoker A; Sardar Z; Yang H; Hussain M
Transplantation; 1999 Oct; 68(8):1188-94. PubMed ID: 10551649
[TBL] [Abstract][Full Text] [Related]
3. CD4+ T lymphocytes expressing CD40 ligand help the IgM antibody response to soluble pneumococcal polysaccharides via an intermediate cell type.
Jeurissen A; Billiau AD; Moens L; Shengqiao L; Landuyt W; Wuyts G; Boon L; Waer M; Ceuppens JL; Bossuyt X
J Immunol; 2006 Jan; 176(1):529-36. PubMed ID: 16365447
[TBL] [Abstract][Full Text] [Related]
4. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
[TBL] [Abstract][Full Text] [Related]
5. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4+ T cell functions.
Oxenius A; Campbell KA; Maliszewski CR; Kishimoto T; Kikutani H; Hengartner H; Zinkernagel RM; Bachmann MF
J Exp Med; 1996 May; 183(5):2209-18. PubMed ID: 8642330
[TBL] [Abstract][Full Text] [Related]
6. Anti-CD40 Antibody Fused to CD40 Ligand Is a Superagonist Platform for Adjuvant Intrinsic DC-Targeting Vaccines.
Ceglia V; Zurawski S; Montes M; Kroll M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
Front Immunol; 2021; 12():786144. PubMed ID: 35095862
[TBL] [Abstract][Full Text] [Related]
7. In vivo helper functions of alloreactive memory CD4+ T cells remain intact despite donor-specific transfusion and anti-CD40 ligand therapy.
Chen Y; Heeger PS; Valujskikh A
J Immunol; 2004 May; 172(9):5456-66. PubMed ID: 15100287
[TBL] [Abstract][Full Text] [Related]
8. Heightened CD40 ligand gene expression in peripheral CD4+ T cells from patients with kidney allograft rejection.
Shoker A; George D; Yang H; Baltzan M
Transplantation; 2000 Aug; 70(3):497-505. PubMed ID: 10949194
[TBL] [Abstract][Full Text] [Related]
9. Different costimulation signals used by CD4(+) and CD8(+) cells that independently initiate rejection of allogenic hepatocytes in mice.
Gao D; Li J; Orosz CG; Bumgardner GL
Hepatology; 2000 Nov; 32(5):1018-28. PubMed ID: 11050052
[TBL] [Abstract][Full Text] [Related]
10. CD40-independent help by memory CD4 T cells induces pathogenic alloantibody but does not lead to long-lasting humoral immunity.
Rabant M; Gorbacheva V; Fan R; Yu H; Valujskikh A
Am J Transplant; 2013 Nov; 13(11):2831-2841. PubMed ID: 24102790
[TBL] [Abstract][Full Text] [Related]
11. CD4+ T lymphocytes with constitutive CD40 ligand in preautoimmune (NZB x NZW)F1 lupus-prone mice: phenotype and possible role in autoreactivity.
Lettesjö H; Burd GP; Mageed RA
J Immunol; 2000 Oct; 165(7):4095-104. PubMed ID: 11034421
[TBL] [Abstract][Full Text] [Related]
12. Activation of alloreactive CD8+ T cells operates via CD4-dependent and CD4-independent mechanisms and is CD154 blockade sensitive.
Zhai Y; Meng L; Busuttil RW; Sayegh MH; Kupiec-Weglinski JW
J Immunol; 2003 Mar; 170(6):3024-8. PubMed ID: 12626556
[TBL] [Abstract][Full Text] [Related]
13. Murine Fibroblastic Reticular Cells From Lymph Node Interact With CD4+ T Cells Through CD40-CD40L.
Nakayama Y; Brinkman CC; Bromberg JS
Transplantation; 2015 Aug; 99(8):1561-7. PubMed ID: 25856408
[TBL] [Abstract][Full Text] [Related]
14. CD40L expression by CD4
Durlanik S; Loyal L; Stark R; Sercan Alp Ö; Hartung A; Radbruch A; von Herrath M; Matzmohr N; Frentsch M; Thiel A
Eur J Immunol; 2016 Nov; 46(11):2566-2573. PubMed ID: 27562840
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticoid-induced TNFR-related protein stimulation reverses cardiac allograft acceptance induced by CD40-CD40L blockade.
Krill KT; Csencsits-Smith K; Wood SC; Faust S; Lu G; Bishop DK
Clin Dev Immunol; 2013; 2013():986859. PubMed ID: 23690829
[TBL] [Abstract][Full Text] [Related]
16. Human antibody response in human peripheral blood leukocyte/severe combined immunodeficient chimeric model is dependent on B and T cell costimulation via CD40/CD40 ligand.
Chen FA; Williams SS; Fanslow WC; Bankert RB
J Immunol; 1995 Sep; 155(6):2833-40. PubMed ID: 7673699
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD40 Antibodies Fused to CD40 Ligand Have Superagonist Properties.
Ceglia V; Zurawski S; Montes M; Bouteau A; Wang Z; Ellis J; Igyártó BZ; Lévy Y; Zurawski G
J Immunol; 2021 Oct; 207(8):2060-2076. PubMed ID: 34551965
[TBL] [Abstract][Full Text] [Related]
18. In vitro IgG1 alloreactive antibody production by circulating memory cells in humans.
Okasha K; Yang H; Shoker AS
Clin Nephrol; 1998 Jul; 50(1):21-7. PubMed ID: 9710343
[TBL] [Abstract][Full Text] [Related]
19. CD40 ligand and MHC class II expression are essential for human peripheral B cell tolerance.
Hervé M; Isnardi I; Ng YS; Bussel JB; Ochs HD; Cunningham-Rundles C; Meffre E
J Exp Med; 2007 Jul; 204(7):1583-93. PubMed ID: 17562816
[TBL] [Abstract][Full Text] [Related]
20. Antibody to gp39, the ligand for CD40 significantly inhibits the humoral response from Graves' thyroid tissues xenografted into severe combined immunodeficient (SCID) mice.
Resetkova E; Kawai K; Enomoto T; Arreaza G; Togun R; Foy TM; Noelle RJ; Volpé R
Thyroid; 1996 Aug; 6(4):267-73. PubMed ID: 8875745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
